![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
IntelliAM AI plc | AQSE:INT | Aquis Stock Exchange | Ordinary Share | GB00BR56LJ77 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 110.00 | 105.00 | 120.00 | 112.50 | 110.00 | 110.00 | 0.00 | 16:29:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/8/2002 19:34 | nigel_s How did you get 207p? I had to buy before I went to work and got 212p. Are you able to watch a real-time ticker all day? Hopefully, seen the bottom, 227.5 tonight. Do y know when interims are out, was August last year. If y do can y recommend a free site that tells you when a company's important financial data is out. I emailed Int the other day and await a reply. I'll post answer if you like. Regards, | annef | |
15/8/2002 07:56 | I have been out of these for a year or so now, but noticed they were looking cheap on Tuesday. I spoke to my brokers who said they could find no reason for the fall other than market conditions. I know these were being short sold at one stage last year, so maybe that was behind this fall also? Anyway, I dipped my toes in with a few when the price stabilised at 207p, and some more yesterday at 215p. From Citywire paper review this morning they quote DAILY EXPRESS * Intercare - WestLB Panmure buy so that might explain the sharp move up yesterday. Results are likely to be out soon, so they may stabilise/move up in the run up to those. | nigel_s | |
16/6/2002 22:36 | Sharecast has the following buy tip from the IC....... Intercare at 270p, healthcare products supplier. Drug developers are facing tough times ahead as their products lose patent protection, but their pain should be Intercare's gain as it is the biggest deliverer of generic drugs in the UK. Sales of generic drugs are set to rise by 12% to 14% a year over the next five years, and an expected rise in healthcare spending should also help drive profits. WestLB Panmure predicts earnings growth of around 33% a year over the next four years. That's assuming that prices for generic drugs remain stable and that the group's aggressive acquisition strategy continues to pay off. | jongame | |
06/6/2002 22:33 | Ah-ha! Realisation has dawned....2% up today but deserves a lot more. Come on you GSK holders move to where the action is going to be! | jongame | |
06/6/2002 13:05 | Like the way you think Jongame. | ljhc | |
04/6/2002 16:49 | The problems that GSK and AstraZenica are having with patents seems to me to play into the hands of the generic drug producers and distributors such as Intercare. Why then no move up in their share price? Has the market not noticed that the dark cloud for the big boys is a silver lining for intercare? | jongame |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions